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Ethnicity and Left Ventricular
Diastolic Function in Hypertension
An ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Substudy
Andrew Sharp, MBCHB,* Robyn Tapp, PHD,*† Darrel P. Francis, MD,* Simon A. McG. Thom, MD,*
Alun D. Hughes, MD, PHD,* Alice V. Stanton, MD, PHD,‡ Andrew Zambanini, MD,*
Nish Chaturvedi, MD,* Sheila Byrd, BSC,* Neil R. Poulter, MD,* Peter S. Sever, MD,*
Jamil Mayet, MD*
London, United Kingdom; Melbourne, Australia; and Dublin, Ireland
Objectives We investigated whether diastolic function differs between hypertensive patients of African-Caribbean or white
European origin and established whether differences could be explained by confounding variables.
Background African Caribbeans are known to have a higher prevalence of heart failure than white Europeans but it is unclear
whether this is a result of known risk factors. Tissue Doppler technology now allows accurate quantification of
diastolic function, which is recognized as an important factor in the development of heart failure.
Methods Participants from a single center participating in the ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial), com-
posed of patients with hypertension but no evidence of heart failure, were studied. Left ventricular structure and
function were measured in 509 patients using conventional and tissue Doppler echocardiography. Diastolic func-
tion was assessed using the tissue Doppler early diastolic velocity E= (averaged from 3 left ventricular segments)
and the ratio of this and the transmitral early filling velocity E (E/E=).
Results In African-Caribbean patients, mean E= was significantly lower (7.7 cm/s vs. 8.6 cm/s, p  0.003) and mean
E/E= was significantly higher (8.85 vs. 7.93, p  0.003). After adjustment for confounding variables—age, gen-
der, systolic blood pressure, pulse pressure, cholesterol, smoking, ejection fraction, left ventricular mass index,
and diabetes mellitus—the effect of African-Caribbean ethnicity on diastolic function remained highly significant
(E=: 7.52 vs. 8.51; p  0.001; E/E=: 8.89 vs. 7.93; p  0.003; African Caribbeans vs. white Europeans for both
comparisons).
Conclusions Diastolic function is significantly worse in hypertensive patients of African-Caribbean origin than in white Europe-
ans. This difference in diastolic performance is not due to known confounding variables. (J Am Coll Cardiol
2008;52:1015–21) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.04.065t
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fersons of black African descent in the Western world
African Americans in the U.S. and African Caribbeans in
he United Kingdom) have a greater risk of heart failure
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008, accepted April 29, 2008.han comparator populations of white European origin (1).
t is not known whether this cardiac dysfunction occurs
ecause of an ethnic difference in myocardial susceptibility,
r because of an increased prevalence of factors that con-
ribute to ventricular dysfunction among African Caribbe-
ns, such as left ventricular hypertrophy (LVH), type 2
See page 1022
iabetes mellitus, obesity, and high blood pressure (BP)
2–4). In addition, interpretation of comparator studies
erformed in patients with established end organ failure is
ade more difficult by possible differential effects of com-
lex treatment regimes. What is required is a study per-
ormed at an earlier stage of disease, with stratification or
djustment for risk factors.
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Ethnicity and LV Diastolic Function September 16, 2008:1015–21The earliest cardiac conse-
quence of hypertension is dia-
stolic dysfunction, which is part
of a continuum of ventricular
impairment ending in systolic
heart failure. However, until rel-
atively recently it has been diffi-
cult to reliably quantify diastolic
dysfunction.
The advent of tissue Doppler
technology has provided a solution
to some of the problems associated
with traditional Doppler echocar-
diography. Rather than interpret-
ing patterns of blood flow, it mea-
sures myocardial velocities directly
and is more reproducible than his-
torically used echocardiographic
methods for assessing diastolic
function, such as the Valsalva ma-
neuver or pulmonary vein flow. It
provides measures that are less af-
fected by volume status or vaso-
dilator drug therapy than are
onventional techniques (5–7), and when combined with
he transmitral early filling wave (E) to form a ratio (E/E=),
rovides an estimate of left atrial filling pressures (5,8,9).
In this study, tissue Doppler was used to investigate
hether diastolic function differs between hypertensive
ersons of African-Caribbean origin and white Europeans,
nd whether any differences observed could be explained by
otential confounding variables.
ethods
he population, methods, and response rate for the AS-
OT (Anglo-Scandinavian Cardiac Outcomes Trial) are
ound in detail elsewhere (10). In brief, ASCOT was a
linical trial of antihypertensive therapy (amlodipine 
erindopril vs. atenolol  bendroflumethiazide) for 19,342
en and women ages 40 to 79 years with hypertension.
etailed cardiovascular phenotypic data were collected on a
ubset of 579 participants recruited at St. Mary’s Hospital,
ondon. Participants were asked to categorize their own
thnicity, and 509 declared themselves to be of white
uropean or African-Caribbean origin. The remaining 70
articipants were of Oriental, South Asian, or mixed eth-
icities and were excluded from this substudy on the
rounds of insufficient numbers within each of those ethnic
roups to allow analysis.
All participants in the study were hypertensive. They had
ither untreated hypertension (systolic BP 160 mm Hg
nd/or diastolic BP 100 mm Hg at both screening and
andomization) or treated hypertension (systolic BP 140
m Hg and/or diastolic BP 90 mm Hg at randomiza-
Abbreviations
and Acronyms
ACE  angiotensin-
converting enzyme
BP  blood pressure
CCB  calcium-channel
blocker
E=  tissue Doppler early
diastolic velocity
E/A ratio  ratio of E-wave
to A-wave
E/E= ratio  ratio of
transmitral early filling
velocity E and E=
ECG  electrocardiogram
LV  left
ventricle/ventricular
LVH  left ventricular
hypertrophy
LVMI  left ventricular
mass index
RWT  relative wall
thicknession), with at least 3 of the following cardiovascular risk ractors: previously identified LVH on echocardiography or
lectrocardiography (ECG [identified before enrollment in
SCOT through previous investigations]), other previously
dentified specific ECG abnormalities, type 2 diabetes
ellitus, peripheral vascular disease, previous transient
schemic attack or stroke, male gender, age 55 years,
icroalbuminuria/proteinuria, smoking, plasma total
holesterol/high-density lipoprotein ratio 6, and family
istory of ischemic heart disease in a first-degree relative
male relative 55 years old at the time, female 60 years
ld). Diabetes was diagnosed on the basis of fasting plasma
lucose 7.0 mmol/l or previous diagnosis of diabetes
ellitus. Demographic data shown are those at baseline for
ategorical variables and those at the time of echocardiog-
aphy for continuous data. Patients with pre-existing isch-
mic heart disease or heart failure were excluded (10).
chocardiography. After a 1-year period of standardized
ntihypertensive therapy according to the ASCOT study
rotocol, all patients underwent echocardiography using an
TL HDI 5000 ultrasound machine (Phillips, Bothell,
ashington) equipped with a 7-4 MHz broadband linear
rray transducer. All scans were performed by 1 of 2
xperienced echocardiographers, with the patient semire-
umbent in the left lateral position. Left ventricular mea-
urements were performed using M-mode from the
arasternal long axis according to the American Society of
chocardiography guidelines (11). Where on-axis M-mode
easures were not possible, measurements were made from
D. Left ventricular mass was calculated according to the
evereux formula (12). This was then indexed for body
urface area to give the left ventricular mass index (LVMI).
elative wall thickness (RWT) was calculated according to
he standard formula of RWT  (2  posterior wall
hickness in diastole)/left ventricular internal diameter in
iastole). Midwall fractional shortening was calculated us-
ng formulas detailed elsewhere (13).
Transmitral Doppler flow velocity was measured using a
-mm sample volume placed at the tips of the mitral leaflets
n passive end expiration. A standardized loop of 10 cardiac
ycles was downloaded to a computer for off-line analysis of
he early filling phase (E-wave) and the late filling phase
A-wave). Tissue Doppler was performed in the apical
-chamber view, with the 5-mm sample volume placed over
he myocardium on the septum at the level of the mitral
nnulus. Using minimalized gain settings, a series of 10
ardiac cycles was recorded. These were then downloaded
or off-line analysis, with measurements made of systolic
otion (S=-wave), early diastolic motion (E=-wave), and late
iastolic motion (A=-wave). The E=-wave velocities from
he septal, lateral, and inferior walls were averaged and the
atio of the transmitral E-wave to E= velocity (E/E= ratio)
alculated. Analysis was performed using the HDI Labora-
ory software (Phillips) by a single researcher (A.S.), who
as masked to all patient details, and each value represents
he mean of 3 measurements taken from 3 consecutive,
epresentative cardiac cycles. Interobserver reproducibility
d
t
a
7
p
S
i
I
(
n
s
u
d
M
C
d
e
a
s
g
c
w
o
d
m
A
e
m
m
c
a
b
a
q
E
w
R
T
a
s
A
r
c
h
L
b
i
P
*
L
A
CD
1017JACC Vol. 52, No. 12, 2008 Sharp et al.
September 16, 2008:1015–21 Ethnicity and LV Diastolic Functionata were acquired for the 2 echocardiographers involved at
he single site used in this study and showed a variation for
ll echocardiographic measurements of between 3.5% and
.5%. This variation is within acceptable limits as per
revious studies (14).
tatistical analysis. Statistical analysis was performed us-
ng SPSS version 14.0 for Windows (SPSS Inc., Chicago,
llinois). Data are presented as mean  SD or median
interquartile range) for skewed data. Skewed data were
ormalized by log10 transformation before statistical analy-
is. Continuous data were analyzed according to ethnicity
sing 1-way analysis of variance (ANOVA), and categorical
ata were analyzed using chi-square tests.
ultivariate analysis. Three multivariate models (AN-
OVA), applied separately to each of the 2 measures of
iastolic function, were built to allow tiered analysis of the
ffect of ethnicity on cardiac function: model 1, adjusted for
ge and gender only; model 2, adjusted for age, gender,
ystolic BP, and diabetes; and model 3, adjusted for age,
ender, systolic BP, pulse pressure, diabetes, smoking, total
holesterol, ejection fraction, and LVMI.
Further analyses were undertaken separately to assess
hether any measures of left ventricular (LV) geometry
ther than LVMI would better explain ethnic differences in
iastolic function (RWT, RWT/height2, left ventricular
ass [LVM]/height2.7) when incorporated into model 3.
dditionally, substituting midwall fractional shortening for
jection fraction within an alternate model 3 was performed.
Models were also constructed incorporating drug treat-
ent arm (calcium-channel blocker vs. beta blocker) into
atient Characteristics
Table 1 Patient Characteristics
White
European
(n  449)
African
Caribbean
(n  60) p Value
Continuous variables, mean  SD
Age (yrs) 64.3 7.6 61.8 6.8 0.018
Systolic blood pressure (mm Hg) 140.4 13.5 143.3 14.3 0.123
Diastolic blood pressure (mm Hg) 79.9 8.1 82.4 7.0 0.024
Pulse pressure (mm Hg) 60.5 12.0 60.9 12.7 0.807
Heart rate (beats/min) 62.7 12.1 62.8 11.0 0.936
Body surface area (m2) 2.0 0.2 2.0 0.2 0.977
BMI (kg/m2) 28.7 4.4 29.0 3.9 0.594
Total cholesterol (mmol/l) 5.9 1.0 5.4 1.2 0.002
Triglycerides (mmol/l)* 1.5 (1.1–2.0) 1.2 (0.8–1.7) 0.001
Categorical variables, n (%)
Males 390 (87) 51 (85) 0.691
Prior known ECG or
echocardiography LVH
106 (23) 21 (35) 0.055
Diabetes mellitus 85 (19) 23 (38) 0.001
Cerebrovascular disease 35 (8) 6 (10) 0.556
Microalbuminuria 243 (54) 39 (65) 0.111
Smoker 104 (23) 14 (23) 0.977
Calcium-channel blocker–based
treatment
227 (51) 26 (43) 0.268
Metabolic syndrome 163 (36) 23 (38) 0.759Data quoted are median (interquartile range).
BMI  body mass index; ECG  electrocardiogram; LVH  left ventricular hypertrophy. Eodel 3. As almost all of the subjects were receiving
ombination therapy (calcium-channel blocker [CCB] plus
ngiotensin-converting enzyme [ACE] inhibitor or beta-
locker and diuretic), a separate analysis for ACE inhibitors
nd diuretics was not undertaken. Marginal means are
uoted, representing the mean values for both E= and for
/E= after adjustment for covariates. A p value of 0.05
as considered statistically significant.
esults
he overall patient characteristics are shown in Table 1 and
re comparable to the population from the ASCOT parent
tudy (15). There were several differences between the
frican-Caribbean and white European groups; white Eu-
opeans were older, had lower diastolic BP, higher total
holesterol, and higher triglycerides. African Caribbeans
ad a higher prevalence of diabetes.
eft ventricular geometry. Although LVMI did not differ
etween groups (Table 2), African Caribbeans had a signif-
cantly greater mean relative wall thickness. These ethnic
V Structural Data
Table 2 LV Structural Data
White
European
African
Caribbean p Value
Interventricular septum,
diastole (cm)
1.25 0.20 1.32 0.21 0.100
LV internal dimension,
diastole (cm)
4.81 0.53 4.67 0.51 0.059
Posterior wall thickness,
diastole (cm)
1.16 0.17 1.24 0.18 0.003
Interventricular septum,
systole (cm)
1.61 0.23 1.75 0.26 0.001
LV internal dimension,
systole (cm)
3.30 0.57 3.00 0.55 0.001
Posterior wall thickness,
systole (cm)
1.56 0.20 1.68 0.25 0.001
LV ejection fraction (%) 66.28 13.16 71.08 14.62 0.010
LVMI (g/m2) 114.02 27.93 118.44 26.69 0.250
Relative wall thickness 0.49 0.09 0.54 0.11 0.001
Left atrial size (cm) 4.34 0.62 4.16 0.50 0.081
ll values are mean  standard deviation.
LV  left ventricular; LVMI  left ventricular mass index.
onventional and Tissueppler Echocar iographic Data
Table 3 Conventional and TissueDoppler Echocardiographic Data
White
European
African
Caribbean p Value
Transmitral Doppler
E-wave (cm/s) 63.41 13.99 63.15 14.78 0.895
A-wave (cm/s) 73.85 15.84 74.51 16.53 0.762
E/A ratio 0.89 0.25 0.87 0.22 0.623
E-wave deceleration
time (ms)
201.40 5.20 199.00 4.60 0.685
Tissue Doppler (cm/s)
Mean E= (cm/s) 8.57 1.84 7.77 1.63 0.003
Mean E/E= ratio 7.93 2.07 8.85 2.39 0.003=  tissue Doppler early diastolic velocity.
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Ethnicity and LV Diastolic Function September 16, 2008:1015–21ifferences in ventricular structure were due to the greater
entricular internal diameters in white Europeans on the
ne hand and to thicker ventricular walls in African Carib-
eans on the other.
iastolic function in the African Caribbeans and white
uropeans. Tissue Doppler echocardiography revealed
lear differences between the 2 ethnic groups (Table 3).
frican Caribbeans had lower mean E= velocity and higher
/E= values than white Europeans. Transmitral Doppler
ow did not differ by ethnicity.
ultivariate analysis for relationship between E= and
thnicity. African Caribbeans had a significantly lower
ean E= velocity than White Europeans, and that difference
emained statistically significant after adjustment for age,
iabetes, systolic BP, pulse pressure, smoking, cholesterol,
nd structural LV differences (7.52 cm/s vs. 8.51 cm/s,
espectively; p  0.001) (Table 4). Additional models
ubstituting other measures of LV geometry for LVMI
RWT, RWT/height2, and LVM/height2.7) were also per-
ormed, but these did not significantly alter the findings.
sing midwall fractional shortening as an alternate measure
f LV function to ejection fraction also did not significantly
lter the findings (data not shown).
ultivariate analysis for relationship between E/E= and
thnicity. African Caribbeans had a significantly higher
ean E/E= ratio than white Europeans, which similarly
emained statistically significant after adjustment for risk fac-
ors and confounding variables (8.89 vs. 7.93, respectively; p
.003) (Table 4). Additional models substituting other mea-
ures of LV structure and function for LVMI (RWT, RWT/
eight2, and LVM/height2.7) or ejection fraction (midwall
ractional shortening) were again performed, but these did not
ignificantly alter the findings (data not shown).
As an imbalance in known diabetes prevalence by ethnic-
ty could have affected our observations through some
nforeseen interaction, all models were rerun after excluding
ll patients with diabetes. The magnitude of the ethnic
ifferences seen in both diastolic measures was essentially
nchanged and remained statistically significant (E= 8.59 vs.
.60, p  0.003; and E/E= 7.87 vs. 8.77; p  0.021). An
ntihypertensive treatment arm (CCB  ACE inhibitor vs.
ultivariate Analysis: Adjusted Values for E= and for E/E= Accordin
Table 4 Multivariate Analysis: Adjusted Values for E= and for E
White European
Model 1 (factors included age, gender)
Adjusted E= 8.60
Adjusted E/E= 7.92
Model 2 (factors included age, gender, diabetes, systolic BP)
Adjusted E= 8.60
Adjusted E/E= 7.94
Model 3 (factors included age, gender, diabetes, systolic BP,
pulse pressure, EF, cholesterol, smoking, LVMI)
Adjusted E= 8.51
Adjusted E/E= 7.93
P  blood pressure; CI  confidence interval; E  transmitral early filling velocity; E=  tissue Deta-blocker  diuretic) was added to the model as an sdditional variable and also did not significantly change the
ndings (data not shown).
Figure 1 demonstrates the magnitude of the ethnic
ifference in these markers of diastolic function in compar-
son with that of each decade of aging.
iscussion
his study shows that African Caribbeans in our study had
greater degree of diastolic impairment than white Euro-
eans, either measured directly through reduced E= or
hrough implied higher left atrial filling pressures, as repre-
ented by an increased E/E= ratio. This ethnic effect was
arge, and using regression coefficients was calculated to be
quivalent to 18 years of aging.
African Caribbeans have a significantly greater risk of
eart failure, renal failure, and stroke compared with white
uropeans (16–19). In these later stages of disease, the
dverse risk factor profile of African Caribbeans, such as a
reater prevalence of diabetes and hypertension, accounts
or some of the excess risk; however, a considerable amount
emains unexplained. In the U.S., it is thought that ineq-
itable access to health care, and therefore poorer treatment
or risk factors, may also contribute to this excess risk. We
ave shown, however, that this excess risk persists even at
uite early stages of disease, independent of other major risk
actors, in a health care and clinical trial setting where care
rovision is equitable. This finding implies that other
xplanations for this excess risk must be sought.
Diastolic function has been compared between ethnicities
n 2 previous studies, with equivocal results. One study of 24
ubjects found a lower transmitral E/A ratio in African
aribbeans (20). Another study investigating 29 African
aribbeans and 29 white Europeans found no such differ-
nce in transmitral E/A ratio, but did find a longer
sovolumic relaxation time in the African Caribbeans (21).
s neither study employed tissue Doppler, these conflicting
ndings may be attributable to the limitations of conven-
ional Doppler in terms of its ability to distinguish normal
unction from “pseudonormalization.” Left atrial diameters
ere mildly increased in both ethnic groups but were not
Ethnicity
ccording to Ethnicity
95% CI African Caribbean 95% CI Difference p Value
.34–8.86 7.59 7.10–8.08 1.01 0.001
.61–8.24 9.00 8.40–9.60 1.08 0.001
.34–8.86 7.65 7.16–8.15 0.95 0.001
.61–8.28 8.86 8.27–9.45 0.92 0.003
.24–8.78 7.52 7.03–8.02 0.99 0.001
.65–8.20 8.89 8.30–9.46 0.96 0.003
early diastolic velocity; EF  ejection fraction; LVMI  left ventricular mass index.g to
/E= A
8
7
8
7
8
7ignificantly different. This finding is consistent with the
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September 16, 2008:1015–21 Ethnicity and LV Diastolic FunctionV mass measurements that were also elevated to a similar
egree in both groups. Neither of these 2 structural mea-
ures was able to detect differences between these groups at
his stage of the disease process. In contrast, tissue Doppler
rovided unambiguous evidence of early impaired diastolic
unction in the African-Caribbean group.
Age affects diastolic function regardless of the method of
easurement (22). In the present study, the age difference
etween the groups was small, and ethnic differences in
iastolic function remained after statistical adjustment for
ge. Differences in BP might also contribute to differences
n diastolic function, as African Caribbeans are not only
nown to have an increased prevalence of hypertension but
lso an increased severity (23). However, in the present
tudy (by design), BP differences in white Europeans and
frican Caribbeans were small, and statistical adjustment
or BP had little impact on the ethnic difference in diastolic
unction.
Left ventricular hypertrophy is another cause of diastolic
ysfunction. Previous studies exploring ethnic differences in
V structure have generally found an increased relative wall
hickness in people of black African descent (24), sometimes
n association with an increase in LV mass (25–27), al-
hough not consistently (28). In our study, LVMI was
imilar in both ethnic groups, probably as a result of
reviously identified LVH being one of several entry criteria
or the study and the close similarity in BP (again as a
onsequence of the entry criteria). Statistical adjustment for
ifferences in LVMI did not attenuate ethnic differences in
iastolic function nor did other methods of adjusting for LV
eometry. It seems unlikely, therefore, that LV geometry
ully explains the more impaired diastolic function seen in
Figure 1 Relationship of Age Group and Ethnicity to Diastolic F
The magnitude of the ethnic difference in these markers of diastolic function in co
Diastolic function was assessed using the tissue Doppler early diastolic velocity (Efrican Caribbeans. tDiabetes mellitus is known to be more common in the
frican-Caribbean population and may be associated with
iastolic dysfunction (29). However, in the present study,
xcluding patients with a diagnosis of diabetes from the
nalysis did not alter the strong association between ethnic-
ty and diastolic function.
Inequality of access to health care and treatments has also
een suggested as a factor mediating poorer outcomes in
ome ethnic groups (1,2). From the onset of randomization
ithin the ASCOT study, all hypertension treatment deci-
ions were strictly protocol based, being uniformly managed
hroughout the trial in a “treat to target” fashion. Also,
efore entry into the trial, all patients within this substudy
eceived their general medical care and hypertension treat-
ent through the United Kingdom National Health Ser-
ice, which provides free “at the point of delivery” access to
ealth care for all. Prescription medicines are given free to
ersons of low incomes and heavily subsidized for others.
ecruitment also took place through local primary care
acilities in a small geographical area, with large numbers
rom the same practices. These factors limit the effects of
ifferences in access and the proposed inequalities of care
een in other health care systems. This is an important
ifference from several previous studies looking at the
onsequences of hypertension in different ethnic groups and
s a strength of the present study.
A study of this nature can identify ethnic differences in
isease patterns but cannot establish underlying mecha-
isms. Our observations exclude previously proposed mech-
nisms, such as those related to comorbidity burden or LV
tructural differences. However, there remain several possi-
le reasons for the observation of greater diastolic dysfunc-
ion, as Measured by E= and the E/E= Ratio
on with that of each decade of aging is demonstrated.
the ratio of this and the transmitral early filling velocity (E/E=).unct
mparis
=) andion in African Caribbeans. First, it may represent an
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Ethnicity and LV Diastolic Function September 16, 2008:1015–21ncreased susceptibility to myocardial impairment in re-
ponse to the same degree of hypertension for reasons
nknown. Second, ethnic differences in renin (30), aldoste-
one (31), and salt sensitivity (32) are well established, but
he relationship of these factors to diastolic dysfunction
emains unclear and therefore we did not adjust for these.
uch factors might have a direct bearing on myocardial
unction. If such factors were to affect our results simply
hrough plasma volume status, this might have an impact on
eft atrial filling pressure, but less so on the tissue Doppler
= velocity, as this is a direct myocardial velocity measure-
ent and is relatively independent of preload variation
7,33,34). Finally, as these findings are entirely in African-
aribbean subjects, further work is also required to examine
ther African populations or those with African heritage
uch as the African-American population.
linical implications. The relatively impaired diastolic
unction found in this study suggests that the greater burden
f heart failure seen in the African-Caribbean hypertensive
opulation may begin to develop from an earlier stage than
reviously thought, in this case well before symptoms have
eveloped. Tissue Doppler E= velocities are a measure of
arly diastolic relaxation and have been shown to progres-
ively deteriorate with increasing diastolic dysfunction and
e closely related to symptoms of heart failure in those with
reserved systolic function (35). The E/E= ratio is also a
arker of left atrial filling pressure, and a higher ratio has
een shown to be an adverse prognostic marker in cardio-
ascular disease (36).
onclusions
frican Caribbeans with treated hypertension have a greater
egree of myocardial dysfunction than their white European
ounterparts, despite good BP control. This difference could
ot be accounted for by known confounding variables and
ay partly explain the increased burden of heart failure in
he African-Caribbean population.
eprint requests and correspondence: Dr. Andrew Sharp, Inter-
ational Centre for Circulatory Health, St. Mary’s Hospital and
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